CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has been recognized by Forbes as one of “The 200 Best Small Companies” for the fourth year in a row. The 200 Best Small Companies list is selected following a comprehensive evaluation of financial results plus additional operating factors of candidate companies having sales between $5 million and $750 million. Additional qualification criteria included a consistent pattern of positive growth during a five-year period as well as over the last twelve months, net profit margins greater than 5% and share prices above $5.00. Meridian Bioscience’s overall ranking was 102 and, in the individual category rankings, Meridian was 13th based upon its five-year average return on equity.
